Newly Diagnosed SLE Associated With Increased Risk for Hip Fractures
Researchers assessed the independent risk of hip fractures in patients with newly diagnosed systemic lupus erythematosus compared with the general population.
Systemic Lupus Erythematosus
Atrial Fibrillation Hospitalization Rate Twice as High in Medicaid Recipients With SLE
Researchers investigated and compared the rates, risks, and risk factors for atrial fibrillation among Medicaid recipients with systemic lupus erythematosus (SLE) and age- and sex-matched Medicaid recipients without SLE.
Anifrolumab Superior to Placebo in Moderate to Severe Systemic Lupus Erythematosus
Although the first phase 3 trial of anifrolumab did not meet its primary end point, other study end points that were met suggested a clinical benefit for the monoclonal antibody in systemic lupus erythematosus.
Glucocorticoid Use Associated With Increased Risk for Cardiovascular Disease in SLE
Researchers addressed the association between cardiovascular risk and glucocorticoids in patients with systemic lupus erythematosus.
Diagnoses of RA, SLE Linked to Increased Opioid Overdose Hospitalization Risk
Researchers compared the rate of opioid overdose-related hospitalizations among patients with systemic lupus erythematosus and rheumatoid arthritis vs the general population.
High Doses of Hydroxychloroquine May Protect Against Thrombosis in SLE
Researchers examined the association of blood levels of hydroxychloroquine with thrombotic events in a longitudinal systemic lupus erythematous cohort.
Specific Factors Identify Cancer Risk in Systemic Lupus Erythematosus
Researchers studied cancer risk in patients with systemic lupus erythematosus and identified specific risk factors.
Item-Level Domain Analysis May Interpret Quality of Life Responses in SLE
Researchers explored the effect of disease activity on specific health-related quality of life over time in patients with systemic lupus erythematosus, using the item response theory longitudinal model.
Disease Flares Common After Discontinuing Immunosuppressants in Systemic Lupus Erythematosus
Researchers assessed the flare rate and predictors after immunosuppressant withdrawal in systemic lupus erythematosus remission.
Novel Diagnostic Test Demonstrates Clinical Utility in Systemic Lupus Erythematosus
Researchers prospectively compared the clinical utility of diagnostic immunology testing with multianalyte assay panel testing in the diagnosis and treatment of systemic lupus erythematosus.
Next post in Systemic Lupus Erythematosus
